Clinical Trials in Houston

Showing 221-240 of 8,625 trials

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

NCT06994676

Study CBX-250-001 is a Phase 1, open-label, dose-escalation study of CBX-250 in participants with relapsed/refractory AML, HR-MDS, CMML, and CML. Participants aged ≥ 12 years are planned to be enrolled. CBX-250 will initially be investigated on a fixed step-up dosing schedule. CBX-250 will be administered subcutaneously in 28-day cycles, with the first study drug dose administered on Cycle 1, Day 1. Cycle 1 will consist of a priming phase over 7 days, and a target phase over 28 days. Participants will continue CBX-250 until progressive disease (PD) or unacceptable toxicity. All subsequent treatment cycles will be 28 days.

High-risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia (CMML)AML - Acute Myeloid Leukemia+1 more

Crossbow Therapeutics, Inc.72 participantsStarted Jul 2025

Duarte, California, United States • Palo Alto, California, United States • Tampa, Florida, United States +8 more locations

RECRUITINGNA< 1 mile

Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine

NCT07147205

To learn more about your experience participating in a virtual Meaning-Centered Psychotherapy group.

PsychotherapyIntegrative Medicine

M.D. Anderson Cancer Center72 participantsStarted Oct 2025

Houston, Texas, United States

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine

Find Trials by Condition in Houston

Study of VYD2311 for the Prevention of COVID-19

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Terumo Aortic Global Endovascular Registry

Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)

An International Observational Study of Adults With Acute Infection

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV